Emerson Erik C.
SEC CIK 1710496 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APUS | Apimeds Pharmaceuticals US, Inc. | CEO, Dir | 750.0K | — | — | 1 | 2025-05-16 | 2025-05-16 |
Most active insiders at APUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Emerson Erik C. made no open-market trades at APUS in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-20 | 2025-05-16 | APUS | Apimeds Pharmaceuticals US, Inc. | Emerson Erik C. | CEO, Dir | A - Grant | $0.00 | +750.0K | 750.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations